ClinicalTrials.gg
RecruitingNCT05980949Updated Nov 12, 2026

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

A Phase 3 interventional study of KarXT in Psychosis Associated With Alzheimer's Disease, sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company. Recruiting at 432 sites in 31 countries. Open to participants aged 55 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company (part of Bristol-Myers Squibb) · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 4 months later.
Updated Nov 12, 2026Site recruiting status changed10 sites added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
55 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 10 studies testing xanomeline in Alzheimer Disease — 10 open to participants now, 10 under way, 10 of them phase 3. xanomeline · Alzheimer Disease.

Planned enrollment
Largest of 10
1,000 · median 463
Started
2023
with 1 other
Phase 3
10 of 10
10 open now
Registered
2nd of 10
by date
Lead sponsor
4 of 10
Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Among the 10 studies testing xanomeline in Alzheimer Disease, this one has the largest planned enrollment, is one of 2 that started in 2023, is one of 10 in phase 3, and was the 2nd registered.

Alzheimer Disease

3,970 studies on the registry are indexed under Alzheimer Disease; 928 are open to participants now.

Browse Alzheimer Disease studies →

Open to participants now

10 of the 10 studies testing xanomeline in Alzheimer Disease are open now, in 12 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

About xanomeline

xanomeline: first FDA approval 2024 (COBENFY). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 643 Alzheimer Disease studies recruiting now, 284 (44%) set no upper age limit and 55 (9%) stop at 75 or younger; 34 take children under 18; 285 take healthy volunteers.

This study: 55 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies testing xanomeline in Alzheimer Disease, or all of them as a file.
02

Study summary

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized or non-randomized) who complete the 38-week CN012-0026 study, 14-week CN012-0027 study or 14-week CN012-0056 study will be eligible to enroll in CN012-0028. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.

03

Conditions studied

  • Psychosis Associated With Alzheimer's Disease

Browse trials for

04

Who can participate

Ages eligible
55 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must have completed study KAR-031 (CN012-0026), KAR-032(CN012-0027), or CN012-0056. This Inclusion criterion is not applicable for Protocol Amendment 07 or later versions.
  • Can understand the nature of the study and protocol requirements and provide a signed (IC) form before any study assessments are performed. If the subject is deemed not competent to provide IC, both the following requirements for consent must be met:

    1. The subject's legally acceptable representative (LAR) must provide IC
    2. The subject must provide informed assent
  • Must have stable living environment. At entry into this study, or any time during the study, if a subject needs to relocate from home, a residential assisted-living facility, or other stable location to a nursing home facility, the Sponsor/Medical Monitor must approve the subject's participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Significant or severe medical conditions that, in the opinion of the Investigator, could jeopardize the safety of the subject, ability to complete or comply with the study procedures or validity of the study results.
  • abnormalities, including any finding(s) from the , laboratory tests, physical examination, or vital signs, at the EOT visit of Study KAR-031 (Visit 19), Study KAR-032 (Visit 12), Study CN012-0056 (Visit 12) that the Investigator, in consultation with the Medical Monitor, are considered to jeopardize the safety of the subject.
  • Subjects participating in another drug or device study or planning on participating in another clinical study during the duration of KAR-033.
  • Other protocol-defined Inclusion/Exclusion criteria apply.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    KarXT

    Xanomeline and Trospium Chloride Capsules

    Drug: KarXT

Interventions

  • DrugKarXT

    Drug pages: Xanomeline · Trospium

    KarXT 20/2 mg TID (total daily dose \[TDD\] 60/6 mg) KarXT 30/3 mg TID (TDD 90/9 mg) KarXT 40/4 mg TID (TDD 120/12 mg) KarXT 50/5 mg TID (TDD 150/15 mg) KarXT 66.7/6.67 mg TID (TDD 200/20 mg)

06

What researchers measure

Primary outcomes

  1. Incidence of treatment-emergent adverse events (TEAEs)

    The number and percentage of participants with TEAEs will be determined

    Time frame: From initial dose through 14 days after the final dose (up to 54 weeks)

Secondary outcomes

  1. Incidence of serious TEAEs

    The number and percentage of participants with serious TEAEs will be determined

    Time frame: From initial dose through 14 days after the final dose (up to 54 weeks)

  2. Incidence of TEAEs leading to withdrawal

    The number and percentage of participants with TEAEs leading to withdrawal will be determined

    Time frame: From initial dose through 14 days after the final dose (up to 54 weeks)

07

Study locations

133 of 432 sites recruiting
  • Local Institution - 1029
    Homewood, Alabama 35209-6809, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1-13H98LK9
    Chandler, Arizona 85224-6231, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1227
    Chandler, Arizona 85224, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1116
    Chandler, Arizona 85286, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1247
    Gilbert, Arizona 85297, United States
    Not yet recruiting
    • Site 1247 · Contact
  • Local Institution - 1217
    Phoenix, Arizona 85006-2528, United States
    Not yet recruiting
    • Site 1217 · Contact
  • Local Institution - 1044
    Phoenix, Arizona 85012-2836, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1220
    Scottsdale, Arizona 85260-6742, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Advanced Research Center, Inc.
    Anaheim, California 92805-5854, United States
    Recruiting
    • Steven Macina, Site 1104 · Contact714-999-6688
  • Local Institution - 1-141NO1DG
    Chino, California 91710, United States
    Not yet recruiting
    • Site 1-141NO1DG · Contact
  • Local Institution - 1244
    Chino, California 91710, United States
    Not yet recruiting
    • Site 1244 · Contact
  • Local Institution - 1001
    Costa Mesa, California 92626, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1151
    Encino, California 91316, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1033
    Encino, California 91436-2201, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1031
    Irvine, California 92612-1246, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1142
    Lancaster, California 93534-2839, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1230
    Long Beach, California 90805, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1117
    Los Alamitos, California 90720-6506, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
    Los Angeles, California 90033-5313, United States
    Recruiting
    • Lon Schneider, Site 1226 · Contact323-442-3715
  • Local Institution - 1228
    Orange, California 92868-2847, United States
    Not yet recruiting
    • Site 1228 · Contact
  • SC3 Research - Pasadena - 960 E. Green St
    Pasadena, California 91106, United States
    Recruiting
    • M. Lorraine Purino, Site 1043 · Contact626-250-2070
  • Local Institution - 1213
    Rancho Cucamonga, California 91730, United States
    Not yet recruiting
    • Site 1213 · Contact
  • Local Institution - 1103
    Sherman Oaks, California 91403-2131, United States
    Completed

    Not enrolling at this site — choose another above.

  • Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS
    Walnut Creek, California 94596, United States
    Recruiting
    • Ira Glick, Site 1007 · Contact925-298-5147
  • Local Institution - 1014
    Colorado Springs, Colorado 80907-5302, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • University of Connecticut Health Center
    Farmington, Connecticut 06030, United States
    Recruiting
    • Neha Jain, Site 1222 · Contact860-790-7354
  • Local Institution - 1013
    Stamford, Connecticut 06905-1206, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1225
    Atlantis, Florida 33462, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1011
    Boca Raton, Florida 33487-2768, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Envision Trials LLC
    Bonita Springs, Florida 34134, United States
    Recruiting
    • Daniel Mandri, Site 1020 · Contact305-819-2909
  • Local Institution - 1015
    Bradenton, Florida 34209-4687, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1156
    Clermont, Florida 34711-5190, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • K2 Medical Research - Winter Garden
    Clermont, Florida 34711-5933, United States
    Recruiting
    • Christopher Galloway, Site 1048 · Contact321-500-5252
  • JY Research Institute Inc
    Cutler Bay, Florida 33189-1230, United States
    Recruiting
    • Suez Oramas Mingo, Site 1138 · Contact305-424-8696
  • Arrow Clinical Trials
    Daytona Beach, Florida 32117-5532, United States
    Recruiting
    • David Billmeier, Site 1023 · Contact386-278-8000
  • Local Institution - 1224
    Deerfield Beach, Florida 33442, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1162
    Delray Beach, Florida 33445-2581, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Integrity Clinical Research LLC - 21st Street
    Doral, Florida 33122-1620, United States
    Recruiting
    • Lucinda Cuervo-Ramos, Site 1164 · Contact305-888-0410
  • Betancourt Research Services
    Doral, Florida 33172-2638, United States
    Recruiting
    • Beatriz Triana, Site 1045 · Contact786-741-2287
  • Local Institution - 1165
    Fort Myers, Florida 33912-4302, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1155
    Hialeah, Florida 33012-3158, United States
    Completed

    Not enrolling at this site — choose another above.

  • Direct Helpers Research Center
    Hialeah, Florida 33012-3618, United States
    Recruiting
    • Manuel Fernandez, Site 1107 · Contact305-828-3555
  • New Life Medical Research Center -3750 W 16th Ave
    Hialeah, Florida 33012-4648, United States
    Recruiting
    • Jorge Betancourt, Site 1120 · Contact305-456-7782
  • Local Institution - 1046
    Hialeah, Florida 33012-5826, United States
    Not yet recruiting
    • Site 1046 · Contact
  • Las Mercedes Medical Research - 4440 West 16th Ave
    Hialeah, Florida 33012, United States
    Recruiting
    • Frank Carlos Alvarez Li, Site 1052 · Contact786-334-6675
  • Local Institution - 1-13JED81K
    Hialeah, Florida 33013, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1237
    Hialeah, Florida 33013, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Galiz Research
    Hialeah, Florida 33016-1814, United States
    Recruiting
    • Jose Gamez, Site 1140 · Contact305-805-0921
  • Nexus Clinical Research Center- NRC
    Homestead, Florida 33030, United States
    Recruiting
    • John Cintron, Site 1229 · Contact
  • Local Institution - 1145
    Homestead, Florida 33032-8187, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Coral Clinic Research
    Homestead, Florida 33032, United States
    Recruiting
    • Nelson Gonzalez, Site 1049 · Contact786-715-2200
  • Homestead Associates in Research Inc-30328 Old Dixie Hwy
    Homestead, Florida 33033, United States
    Recruiting
    • Angel Carrasco, Site 1159 · Contact786-422-7374
  • Local Institution - 1127
    Largo, Florida 33777-1359, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • K2 Medical Research - Maitland
    Maitland, Florida 32751-5669, United States
    Recruiting
    • Brandon Lenox, Site 1039 · Contact407-670-5833
  • Local Institution - 1146
    Maitland, Florida 32751-6138, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Premier Clinical Research Institute
    Miami, Florida 33122-1335, United States
    Recruiting
    • Emelina Arocha, Site 1021 · Contact305-445-5994
  • Angels Clinical Research Institute - Miami
    Miami, Florida 33122-1721, United States
    Recruiting
    • Yanely Pineiro Puebla, Site 1118 · Contact786-218-1733
  • Local Institution - 1005
    Miami, Florida 33125-3724, United States
    Not yet recruiting
    • Site 1005 · Contact
  • CCM Clinical Research Group
    Miami, Florida 33133-4231, United States
    Recruiting
    • Francisco Ricart, Site 1108 · Contact208-346-8900
  • Wellness Research Center Inc - Miami
    Miami, Florida 33135-1601, United States
    Recruiting
    • Brian Villa, Site 1125 · Contact786-238-7099
  • A & D Doctor Center
    Miami, Florida 33135-2968, United States
    Recruiting
    • Yordan Orive Gomez, Site 1236 · Contact305-223-2000
  • Floridian Neuroscience Institute-1901 SW 1 St
    Miami, Florida 33135, United States
    Recruiting
    • Emilio Mantero-Atienza, Site 1115 · Contact305-326-0776
  • Local Institution - 1010
    Miami, Florida 33137, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • MedOne Clinical Research LLC
    Miami, Florida 33145-2455, United States
    Recruiting
    • Thierry Jacquemin, Site 1143 · Contact305-359-7666
  • Allied Biomedical Research Institute
    Miami, Florida 33155-4630, United States
    Recruiting
    • Michael Pfeffer, Site 1009 · Contact866-879-2507
  • My Community Research Center, Inc - 7480 Bird Rd
    Miami, Florida 33155-6630, United States
    Recruiting
    • Cesar Guerrero, Site 1113 · Contact786-359-4867
  • Future Care Solution LLC
    Miami, Florida 33165-3947, United States
    Recruiting
    • Pilar Trueba, Site 1129 · Contact305-888-0410
  • Reliant Medical Research
    Miami, Florida 33165, United States
    Recruiting
    • Carlos Ramirez Calderon, Site 1150 · Contact786-801-0912
  • South Florida Research Phase I-IV, Inc. - Miami
    Miami, Florida 33166, United States
    Recruiting
    • Silvia Silva Duluc, Site 1053 · Contact305-669-6166
  • Novel Clinical Research Center, LLC -7000 SW 97th Ave
    Miami, Florida 33173-1474, United States
    Recruiting
    • Heber Varela, Site 1006 · Contact000-000-0000
  • Dade Research Center - Miami FL - 7600 SW 87th Ave
    Miami, Florida 33173, United States
    Recruiting
    • Maria Nualart, Site 1111 · Contact305-263-7120
  • Florida Research Center, Inc.
    Miami, Florida 33174-2950, United States
    Recruiting
    • Sonia Rente, Site 1109 · Contact305-551-8493
  • Local Institution - 1158
    Miami, Florida 33175, United States
    Completed

    Not enrolling at this site — choose another above.

  • Serenity Research Center
    Miami, Florida 33176-1451, United States
    Recruiting
    • Sergio Jaramillo, Site 1235 · Contact305-596-2080
  • IMIC LLC- 9380 SW 150th Str
    Miami, Florida 33176-7947, United States
    Recruiting
    • Leon Ramon, Site 1147 · Contact786-600-7005
  • New Gen Health
    Miami, Florida 33176, United States
    Recruiting
    • Roberto Hernando, Site 1234 · Contact305-892-1035
  • Local Institution - 1105
    Miami, Florida 33179-2537, United States
    Completed

    Not enrolling at this site — choose another above.

  • High Quality Research
    Miami, Florida 33184-1412, United States
    Recruiting
    • Jorge Gonzalez, Site 1157 · Contact305-392-0244
  • Coral Research Clinic & Coral Diagnostic Center
    Miami, Florida 33186-4643, United States
    Recruiting
    • Jorge Paoli Bruno, Site 1054 · Contact000-000-0000
  • ONHEALTH Research Center
    Miami, Florida 33186-5882, United States
    Recruiting
    • Maria Rodil, Site 1042 · Contact786-808-0832
  • New Med Research
    Miami Gardens, Florida 33056-4000, United States
    Recruiting
    • Marta Fernandez, Site 1126 · Contact305-269-7100
  • San Marcus Research Clinic Inc
    Miami Lakes, Florida 33014-5602, United States
    Recruiting
    • Nancy Navarro Gonzalez, Site 1032 · Contact
  • Meridian International Research
    Miami Lakes, Florida 33014-6435, United States
    Recruiting
    • Gonzalo Quesada, Site 1102 · Contact305-705-4494
  • Local Institution - 1209
    Miami Lakes, Florida 33014, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Ocean Blue Medical Research Center Inc
    Miami Springs, Florida 33166-5260, United States
    Recruiting
    • Antonio Terrelonge, Site 1026 · Contact305-885-8983
  • Local Institution - 1246
    Naples, Florida 34105, United States
    Not yet recruiting
    • Site 1246 · Contact
  • Local Institution - 1212
    Ocoee, Florida 34761-2964, United States
    Not yet recruiting
    • Site 1212 · Contact
  • Local Institution - 1101
    Okeechobee, Florida 34972-2568, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Nova Psychiatry
    Orlando, Florida 32803, United States
    Recruiting
    • David Medina, Site 1242 · Contact407-823-8421
  • Local Institution - 1136
    Orlando, Florida 32806-1041, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Combined Research Orlando Phase I-IV LLC
    Orlando, Florida 32807-3555, United States
    Recruiting
    • Eric Carbonell, Site 1112 · Contact407-440-4493
  • Neurology Associates of Ormond Beach
    Ormond Beach, Florida 32174-3101, United States
    Recruiting
    • David McDonald, Site 1204 · Contact386-673-2500
  • Local Institution - 1012
    Pensacola, Florida 32504-8608, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1137
    Port Orange, Florida 32127-2914, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1205
    Port Orange, Florida 32127, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1008
    St. Petersburg, Florida 33713-8844, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Local Institution - 1133
    Sweetwater, Florida 33182, United States
    Completed

    Not enrolling at this site — choose another above.

  • Local Institution - 1041
    Tampa, Florida 33607-4629, United States
    Not yet recruiting
    • Site 1041 · Contact
  • Angels Clinical Research Institute Tampa - Palm Springs - PPDS
    Tampa, Florida 33614-2869, United States
    Recruiting
    • Al Robaina, Site 1123 · Contact813-931-0128
  • Guardian Angel Research
    Tampa, Florida 33614, United States
    Recruiting
    • Sadaf Bazargan, Site 1124 · Contact813-300-3300

Showing the first 100 of 432 sites across 31 countries. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: Yes — BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: See Plan Description

Access criteria: See Plan Description

Data sharing details ↗ · www.bms.com

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2023 (actual). Primary completion is estimated for Sep 2027, 49 months after the start.

Of 75 industry-sponsored phase 3 interventional studies under Alzheimer Disease, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 61. This study's planned 49 months is above that.

Counting every sponsor, half of 101 studies reached it within 47 months; a quarter within 28 and three quarters within 73.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2023
First posted
Aug 8, 2023
StartActual
Jul 11, 2023
Primary completionEst.
Sep 7, 2027
CompletionEst.
Sep 7, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
10 sites added, 7 sites removed. Local Institution - 7214 is now Withdrawn
Show 10 added (3 China, 1 Italy, 1 Poland, 1 Portugal, 1 Turkey (Türkiye), 1 United States, 1 Argentina, 1 Spain)
  • Tongji Hospital of Tongji University · Shanghai, China
  • People's Hospital of Zhejiang Province · Hangzhou, China
  • Local Institution - 7030 · Ningbo, China
  • IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli · Brescia, Italy
  • Local Institution - 4217 · Lodz, Poland
  • ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS · Lisbon, Portugal
  • Hacettepe University Medical Faculty · Ankara, Turkey (Türkiye)
  • Local Institution - 1244 · Chino, United States
  • Organización Médica de Investigación · Buenos Aires, Argentina
  • Hospital Provincial de Zamora · Zamora, Spain
Show 7 removed
  • Local Institution - 7028 · Shanghai, China
  • Zhejiang Provincial People's Hospital · Hangzhou, China
  • Local Institution - 2324 · Brescia, Italy
  • Local Institution - 2705 · Lisbon, Portugal
  • Local Institution - 4706 · Ankara, Turkey (Türkiye)
  • Local Institution - 5009 · Ciudad Autónoma de Buenos Aires, Argentina
  • Local Institution - 2202 · Zamora, Spain
across 3 updates, Sep 29, 2026 – Nov 12, 2026
Site contacts
Changed at 2 sites. See the sites
Show 2 sites
  • The Affiliated Brain Hospital of Guangzhou Medical University · Guangzhou, ChinaContact •••0392→•••7968
  • Local Institution - 7214 · Ansan-si, South KoreaContact removed (no phone or email listed)
across 2 updates, Sep 29, 2026 – Oct 16, 2026
Show all 3 updates
  1. Nov 12, 2026
    1 site added, 1 site removed
    Show site
    • Hospital Provincial de Zamora · Zamora, Spain
    Show 1 removed
    • Local Institution - 2202 · Zamora, Spain
    + 1 other change: verification date
  2. Oct 16, 2026
    2 sites added, 1 site removed. Local Institution - 7214 is now Withdrawn
    Show 2 added (1 United States, 1 Argentina)
    • Local Institution - 1244 · Chino, United States
    • Organización Médica de Investigación · Buenos Aires, Argentina
    Show 1 removed
    • Local Institution - 5009 · Ciudad Autónoma de Buenos Aires, Argentina
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Local Institution - 7214 · Ansan-si, South KoreaContact removed (no phone or email listed)
    + 1 other change: verification date
  3. Sep 29, 2026
    7 sites added, 5 sites removed
    Show 7 added (3 China, 1 Italy, 1 Poland, 1 Portugal, 1 Turkey (Türkiye))
    • Tongji Hospital of Tongji University · Shanghai, China
    • People's Hospital of Zhejiang Province · Hangzhou, China
    • Local Institution - 7030 · Ningbo, China
    • IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli · Brescia, Italy
    • Local Institution - 4217 · Lodz, Poland
    • ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS · Lisbon, Portugal
    • Hacettepe University Medical Faculty · Ankara, Turkey (Türkiye)
    Show 5 removed
    • Local Institution - 7028 · Shanghai, China
    • Zhejiang Provincial People's Hospital · Hangzhou, China
    • Local Institution - 2324 · Brescia, Italy
    • Local Institution - 2705 · Lisbon, Portugal
    • Local Institution - 4706 · Ankara, Turkey (Türkiye)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • The Affiliated Brain Hospital of Guangzhou Medical University · Guangzhou, ChinaContact •••0392→•••7968
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05980949
Responsible party
Sponsor
First posted
Aug 8, 2023
Start date
Jul 11, 2023
Primary completion
Sep 7, 2027 (estimated)
Completion
Sep 7, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Contact
Clinical.Trials@bms.com
855-907-3286
First line of the email MUST contain NCT # and Site #.
Contact
Bristol-Myers Squibb
study director · Bristol-Myers Squibb

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Xanomeline · Trospium

Start the discussion